This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.


2023 Global Migraine Research Grant


The 2023 Global Migraine Research Grant from Pfizer supports migraine research worldwide, specifically:

  • Research on the therapeutic application of an oral CGRP antagonist, rimegepant, in migraine, headache, and other diseases where CGRP antagonism may be of clinical benefit
  • The development of tools for clinicians and patients to improve the care of migraine patients
  • Research regarding health disparities associated with migraine

The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or an advanced degree in Pharmacy, Physiotherapy, Psychology, Social Work or Public Health. Applicant must be affiliated with a host institution. Applicants may apply for up to 500,000 USD, including up to 28% in overhead costs.

Letters of intent have been extended to March 1, 2023. Invited full applications are due in June 2023.

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts


Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.